Scholarlink

Background <p>Migraine is a multifactorial disorder in which headaches usually last from 4 to 72&#xa0;h. Sphenopalatine ganglion blockage (SPGB) has been used as a minimal invasive method for alleviating pain in severe headaches.</p> Aim <p>We discuss our technique of performing SPGB and assessment of pain relief, before and after its application. We have also made an effort to study the prevalence of depression and quality of life by scoring patients of chronic migraine and assess how SPGB helps to reduce the incidence of depression and quality of life.</p> Materials and methods <p>Observational and interventional clinical study. Pain scores were recorded using the numeric rating score (NRS) prior to and 15&#xa0;min after SPGB. Patients were also assessed for prevalence of depression and quality of life– based on 2 questionnaires (PHQ-9 and WHO-5)– before and 2 weeks after performing SPGB.</p> Results <p>After intervention by SPGB, there was a statistically significant (p value &lt; 0.001) reduction of pain, the mean scores reduced from 7.41 <b>+/-</b> 2 to 2.02 +/- 1.57. Improvement in quality of life and a statistically significant reduction of depression scores after intervention were seen. The prevalence of depression significantly decreased after SPGB.</p> Conclusion <p>SPGB is a minimally invasive, effective, focused and practical treatment for migraines. Improved quality of life and likelihood of reduction of depressive symptoms after SPGB will also alter the overall well-being of these patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Effectiveness of Sphenopalatine Ganglion Block and its Assessment To the Quality of Life in Patients of Chronic Migraine

  • 期刊论文

  • 发表日期：

    2025年7月16日

查看全文
  • Hemanth Vamanshankar,
  • Zahra Jaafar Abdulla Ahmed Rashed,
  • Hasan Abdulhadi Isa Ali Saeed

摘要

Background

Migraine is a multifactorial disorder in which headaches usually last from 4 to 72 h. Sphenopalatine ganglion blockage (SPGB) has been used as a minimal invasive method for alleviating pain in severe headaches.

Aim

We discuss our technique of performing SPGB and assessment of pain relief, before and after its application. We have also made an effort to study the prevalence of depression and quality of life by scoring patients of chronic migraine and assess how SPGB helps to reduce the incidence of depression and quality of life.

Materials and methods

Observational and interventional clinical study. Pain scores were recorded using the numeric rating score (NRS) prior to and 15 min after SPGB. Patients were also assessed for prevalence of depression and quality of life– based on 2 questionnaires (PHQ-9 and WHO-5)– before and 2 weeks after performing SPGB.

Results

After intervention by SPGB, there was a statistically significant (p value < 0.001) reduction of pain, the mean scores reduced from 7.41 +/- 2 to 2.02 +/- 1.57. Improvement in quality of life and a statistically significant reduction of depression scores after intervention were seen. The prevalence of depression significantly decreased after SPGB.

Conclusion

SPGB is a minimally invasive, effective, focused and practical treatment for migraines. Improved quality of life and likelihood of reduction of depressive symptoms after SPGB will also alter the overall well-being of these patients.